It has been a very effective medication for lowering blood sugar for many years, with the added benefit of weight loss .[1] In response to the weight loss seen in patients with type II diabetes, Novo Nordisk sent semaglutide into FDA trials for approval as a weight loss medication
This should always happen under medical supervision
Lyophilisation is a complex freeze-drying process that removes water from a biological or chemical sample while preserving its molecular structure
Just a few years later, in 2021, the FDA approved semaglutide at a 2.4 mg dose specifically for chronic weight management in adults with obesity or overweight conditions
Mild tiredness can be part of the adjustment process, but certain symptoms deserve medical attention
In a major clinical trial called STEP 8, researchers compared the two medications directly